Comparative Performance Assessment of Point-of-Care Testing Devices for Measuring Glucose and Ketones at the Patient Bedside
Open accessThe DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index.
Abstract
Background: Point-of-care (POC) testing devices for monitoring glucose and ketones can play a key role in the management of dysglycemia in hospitalized diabetes patients. The accuracy of glucose devices can be influenced by biochemical changes that commonly occur in critically ill hospital patients and by the medication prescribed. Little is known about the influence of these factors on ketone POC measurements. The aim of this study was to assess the analytical performance of POC hospital whole-blood glucose and ketone meters and the extent of glucose interference factors on the design and accuracy of ketone results. Methods: StatStrip glucose/ketone, Optium FreeStyle glucose/ketone, and Accu-Chek Performa glucose were also assessed and results compared to a central laboratory reference method. The analytical evaluation was performed according to Clinical and Laboratory Standards Institute (CLSI) protocols for precision, linearity, method comparison, and interference. Results: The interferences assessed included acetoacetate, acetaminophen, ascorbic acid, galactose, maltose, uric acid, and sodium. The accuracies of both Optium ketone and glucose measurements were significantly influenced by varying levels of hematocrit and ascorbic acid. StatStrip ketone and glucose measurements were unaffected by the interferences tested with exception of ascorbic acid, which reduced the higher level ketone value. The accuracy of Accu-Chek glucose measurements was affected by hematocrit, by ascorbic acid, and significantly by galactose. The method correlation assessment indicated differences between the meters in compliance to ISO 15197 and CLSI 12-A3 performance criteria. Conclusions: Combined POC glucose/ketone methods are now available. The use of these devices in a hospital setting requires careful consideration with regard to the selection of instruments not sensitive to hematocrit variation and presence of interfering substances.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“High hematocrit will increase or decrease the measured glucose, or will have minimal effect, depending on the design of the measuring system (132,133).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [133]
In the citing paper
“Several sugars-notably maltose, galactose, and xylose-falsely increase results of some glucose meters.”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [133]
Citations
Cites
Joint British Diabetes Societies guideline for the management of diabetic ketoacidosis
Savage, M. W., Dhatariya, K. K., Kilvert, A., Rayman, G., Rees, J. A. E., Courtney, C. H., Hilton, L., Dyer, P. H., Hamersley, M. S., & Societies, F. T. J. B. D. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03246.x · Cited by 338 · cited 1×
“Recent guidelines have advocated the use of whole-blood measurement of BHB for the management of DKA and for monitoring target directed therapy.(6,7) 563351 DSTXXX10.”
MethodDiabetic ketoacidosis in children and adolescents with diabetes
Wolfsdorf, J., Craig, M. E., Daneman, D., Dunger, D., Edge, J., Lee, W., Rosenbloom, A., Sperling, M., & Hanas, R. (2009) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2009.00569.x · Cited by 313
Glucose Measurement: Confounding Issues in Setting Targets for Inpatient Management
Dungan, K., Chapman, J., Braithwaite, S. S., & Buse, J. (2007) · Diabetes Care · doi:10.2337/dc06-1679 · Cited by 292
Glucose control in the intensive care unit
Fahy, B. G., Sheehy, A. M., & Coursin, D. B. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181a19ceb · Cited by 170
The Accuracy of Point-of-Care Glucose Measurements
Rebel, A., Rice, M. A., & Fahy, B. G. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600228 · Cited by 144 · cited 1×
“A wide range of endogenous and exogenous substances present in the blood of critically ill patients can donate electrons to nonspecifically initiate the electrochemical reaction and cause interference with glucose results, giving elevated values.(13) An increasingly large number of interfering factors have been associ…”
BackgroundResuscitation After Severe Burn Injury Using High-Dose Ascorbic Acid: A Retrospective Review
Kahn, S. A., Beers, R. J., & Lentz, C. W. (2011) · Journal of Burn Care & Research · doi:10.1097/bcr.0b013e318204b336 · Cited by 137
Interference of Maltose, Icodextrin, Galactose, or Xylose with Some Blood Glucose Monitoring Systems
Schleis, T. G. (2007) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.9.1313 · Cited by 102 · cited 2×
“The enzymes used in some handheld POC glucose devices have been reported not to be specific for glucose and shown to react in the presence of maltose and galactose.(14) Similarly it was recently reported that Optium BHB measurements were adversely influenced by acetoacetate, suggesting poor specificity of the BHB dehy…”
MethodResultArora, S., Henderson, S. O., Long, T. E., & Menchine, M. D. (2011) · Diabetes Care · doi:10.2337/dc10-1844 · Cited by 88
Heinemann, L. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0076 · Cited by 69 · cited 1×
“However, it has been well reported that the accuracy of many hospital glucose meters can be affected by the biochemical and physiological changes that commonly occur in acute, chronic, and critically ill hospital patients and also by the medication prescribed.(11,12) A wide range of endogenous and exogenous substances…”
BackgroundHyperglycaemia in critically ill patients: marker or mediator of mortality?
Corstjens, A. M., van der Horst, I. C. C., Zijlstra, J. G., Groeneveld, A. B. J., Zijlstra, F., Tulleken, J. E., & Ligtenberg, J. J. M. (2006) · Critical Care · doi:10.1186/cc4957 · Cited by 68
Research works printed but not linked: 7
- Charles RA, 2007, Singapore Med J, 48, 986
- Clinical and Laboratory Standards Institute, 2004, Evaluation of Precision Performance of Quantitative Measuring Methods; Approved Guideline—Second Edition
- Clinical and Laboratory Standards Institute, 2013, Measurement Procedure Comparison and Bias Estimation Using Patient Samples; Approved Guideline—Third Edition
- Clinical and Laboratory Standards Institute, 2005, Interference Testing in Clinical Chemistry. Approved Guideline—Second Edition
- Clinical and Laboratory Standards Institute, 2003, Evaluation of the Linearity of Quantitative Measurement Procedures: A Statistical Approach; Approved Guideline
- International Organization for Standardization, 2013, In Vitro Diagnostic Test Systems—Requirements for Blood Glucose Monitoring Systems for Selftesting in Managing Diabetes Mellitus
- Clinical and Laboratory Standards Institute, 2013, Point of Care Blood Glucose Testing in Acute and Chronic Care Facilities. Approved Guideline—Third Edition
Cited by
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Diabetes Care · doi:10.2337/dci23-0036 · Cited by 351
Sacks, D. B., Arnold, M. A., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvad080 · Cited by 203
Dhatariya, K. (2016) · The Review of Diabetic Studies · doi:10.1900/rds.2016.13.217 · Cited by 119
Exogenous Ketone Supplements in Athletic Contexts: Past, Present, and Future
Evans, M., McClure, T. S., Koutnik, A. P., & Egan, B. (2022) · Sports Medicine · doi:10.1007/s40279-022-01756-2 · Cited by 93
“For example, recovery of βHB assayed by enzymatic technique indicated that the FreeStyle Optium POC device (Abbott Laboratories, UK) overestimates [R-βHB], whereas the StatStrip POC device (Nova Biomedical, USA) underestimated R-βHB [114].”
MethodHager, D. N., Hooper, M. H., Bernard, G. R., Busse, L. W., Ely, E. W., Fowler, A. A., Gaieski, D. F., Hall, A. J., Hinson, J. S., Jackson, J. C., et al. (2019) · Trials · doi:10.1186/s13063-019-3254-2 · Cited by 77
Metadata
- Authors
- Ceriotti, F., Kaczmarek, E., Guerra, E., Mastrantonio, F., Lucarelli, F., Valgimigli, F., & Mosca, A.
- Affiliations
- IRCCS Ospedale San Raffaele (IT)
- Menarini Group (Italy) (IT)
- University of Milan (IT)
- Corresponding author
- Ceriotti, Ferruccio
- Venue
- Journal of Diabetes Science and Technology
- Publisher
- SAGE Publications
- Published
- 2014-12-17
- Volume
- 9
- Issue
- 2
- Pages
- 268-277
- ISSN
- 1932-2968 (ISSN-L)
- PMC
- PMC4604596
- OpenAlex
- W2156229084
- Semantic Scholar
- bd6fed17a5bdaf987d5645a903f1747f69a1ec33
- Cited by
- 45
- References
- 34
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 2 · 2023: 5 · 2022: 6 · 2021: 6 · 2020: 1 · 2019: 7 · 2018: 4 · 2017: 4 · 2016: 4 · 2015: 2
- FWCI
- 2.22
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Diabetes Science and Technology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Keywords
- point-of-care testing, glucose interference, ascorbic acid interference, hematocrit, acetoacetate, hospitalized diabetes patients, method comparison, ISO 15197, critically ill patients
- MeSH terms
- Blood Glucose, Female, Humans, Ketones, Male, Monitoring, Physiologic, Point-of-Care Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparative Performance Assessment of Point-of-Care Testing Devices for Measuring Glucose and Ketones at the Patient Bedside. https://app.cochat.ai/papers/10.1177/1932296814563351
- The paper
- Ceriotti, F., Kaczmarek, E., Guerra, E., Mastrantonio, F., Lucarelli, F., Valgimigli, F., & Mosca, A. (2015). Comparative Performance Assessment of Point-of-Care Testing Devices for Measuring Glucose and Ketones at the Patient Bedside. Journal of Diabetes Science and Technology. https://doi.org/10.1177/1932296814563351
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.